Equities
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Profile data is unavailable for this security.

About the company

Gerresheimer AG is a Germany-based company that is active in the pharmaceuticals and health care industry. It operates through two business segments: Plastics and Devices, and Primary Packaging Glass. The Plastics and Devices segment produces standard and customized products for drug delivery, such as insulin pens, inhalers, and prefillable syrings. The Primary Packaging Glass segment focuses on the production of packaging of glass for medicines and cosmetics, such as pharmaceuticals jars, ampoules, injection vials, cartridges, perfume flacons and cream jars, as well as glass containers for the food and beverage industry. The Company operates approximately 40 production facilities in Europe, North America, South America and Asia.

  • Revenue in EUR (TTM)2.09bn
  • Net income in EUR78.70m
  • Incorporated2007
  • Employees13.63k
  • Location
    Gerresheimer AGKlaus-Bungert-Strasse 4DUESSELDORF 40468GermanyDEU
  • Phone+49 211618100
  • Fax+49 2 116181295
  • Websitehttps://www.gerresheimer.com/
More ▼

Institutional shareholders

39.25%Per cent of shares held by top holders
HolderShares% Held
Goldman Sachs Asset Management BVas of 23 Jun 20253.70m10.72%
Norges Bank Investment Managementas of 05 Mar 20251.35m3.92%
Deka Investment GmbHas of 28 Jan 20251.30m3.76%
The Vanguard Group, Inc.as of 04 Jun 20251.28m3.71%
Asset Value Investors Ltd.as of 18 Mar 20251.09m3.15%
Lazard Asset Management Ltd.as of 29 Aug 20241.03m2.99%
Artisan Partners LPas of 01 Oct 2024981.94k2.84%
Eminence Capital LPas of 02 Jun 2025960.85k2.78%
Teacher Retirement System of Texasas of 04 Apr 2025946.30k2.74%
Amundi Asset Management SASU (Investment Management)as of 04 Apr 2025913.16k2.64%
More ▼
Data from 31 Dec 2024 - 02 Jul 2025Source: FactSet Research Systems Inc.
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.